ATE269410T1 - Expressionsplasmide für chaperone - Google Patents

Expressionsplasmide für chaperone

Info

Publication number
ATE269410T1
ATE269410T1 AT98111348T AT98111348T ATE269410T1 AT E269410 T1 ATE269410 T1 AT E269410T1 AT 98111348 T AT98111348 T AT 98111348T AT 98111348 T AT98111348 T AT 98111348T AT E269410 T1 ATE269410 T1 AT E269410T1
Authority
AT
Austria
Prior art keywords
chaperones
expression plasmids
cotransformant
foreign protein
operon
Prior art date
Application number
AT98111348T
Other languages
English (en)
Inventor
Kazuyo Sogo
Hideki Yanagi
Takashi Yura
Original Assignee
Hsp Res Inst Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hsp Res Inst Inc filed Critical Hsp Res Inst Inc
Application granted granted Critical
Publication of ATE269410T1 publication Critical patent/ATE269410T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Botany (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
AT98111348T 1997-06-20 1998-06-19 Expressionsplasmide für chaperone ATE269410T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP18055897A JP3344618B2 (ja) 1997-06-20 1997-06-20 シャペロン発現プラスミド

Publications (1)

Publication Number Publication Date
ATE269410T1 true ATE269410T1 (de) 2004-07-15

Family

ID=16085388

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98111348T ATE269410T1 (de) 1997-06-20 1998-06-19 Expressionsplasmide für chaperone

Country Status (6)

Country Link
US (1) US6159708A (de)
EP (1) EP0885967B1 (de)
JP (1) JP3344618B2 (de)
AT (1) ATE269410T1 (de)
CA (1) CA2235468C (de)
DE (1) DE69824487T2 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5881826A (en) 1997-02-13 1999-03-16 Actisystems, Inc. Aphron-containing well drilling and servicing fluids
JP2000083670A (ja) * 1998-09-09 2000-03-28 Hsp Kenkyusho:Kk ＤｓｂＡ／ＤｓｂＢ／ＤｓｂＣ／ＤｓｂＤ発現プラスミド
JP4249832B2 (ja) * 1998-12-28 2009-04-08 タカラバイオ株式会社 トリガーファクター発現プラスミド
US6440715B1 (en) * 1999-03-12 2002-08-27 New England Biolabs, Inc. Method for cloning and expression of Rhodothermus Obamensis DNA polymerase I large fragment in E. coli
EP1048732A1 (de) * 1999-04-26 2000-11-02 F. Hoffmann-La Roche Ag Verfahren zur Herstellung von natürlich gefalteten und sekretierten Proteinen
FI109361B (fi) * 1999-05-04 2002-07-15 Korpela Timo Mikrobinen proteiinin ilmentämisjärjestelmä
EP1149909A1 (de) * 2000-04-28 2001-10-31 Boehringer Mannheim Gmbh Verfahren zur Kontrolle der Konformation eines Proteins mittels molekularen Chaperons
US6495360B1 (en) * 1999-05-28 2002-12-17 Photogen, Inc. Method for enhanced protein stabilization and for production of cell lines useful for production of such stabilized proteins
EP1077263A1 (de) 1999-07-29 2001-02-21 F.Hoffmann-La Roche Ag Verfahren zur Herstellung von natürlich gefalteten und sekretierten Proteinen durch Co-Sekretion von Chaperonen
US7378096B2 (en) * 1999-09-30 2008-05-27 Health Research, Inc. Stress protein compositions and methods for prevention and treatment of cancer and infectious disease
DE10046960A1 (de) * 2000-09-22 2002-04-11 Roche Diagnostics Gmbh Verfahren zur Herstellung einer aktiven, heterodimeren AMW-RT in prokaryotischen Zellen
DE10121235A1 (de) * 2001-04-30 2002-10-31 Roche Diagnostics Gmbh Verfahren zur Expression von Proteinen in in vitro Translations-Systemen unter Ko-Expression von Faltungshelferproteinen
US6960465B1 (en) * 2001-06-27 2005-11-01 Northwestern University Increased cell resistance to toxic organic substances
DE10145694A1 (de) * 2001-09-17 2003-04-03 Roche Diagnostics Gmbh Verfahren zur Erhöhung der Löslichkeit, der Expressionsrate und der Aktivität von Proteinen während der rekombinanten Herstellung
WO2003057897A2 (en) * 2002-01-07 2003-07-17 European Molecular Biology Laboratory Recombinant protein expression
EP1382614A1 (de) * 2002-07-15 2004-01-21 Bayer HealthCare AG Verfahren zur Reinigung von Interleukin-4 und seinen Muteinen
LT5053B (lt) 2002-12-24 2003-09-25 Biotechnologijos Institutas Šaperonai dnak, dnaj ir grpe iš meiothermus ruber, pasižymintys padidintu terminiu stabilumu ir baltymų aktyvios struktūros atstatymo (refoldavimo) in vitro sistema ir būdas
JP2004357586A (ja) * 2003-06-04 2004-12-24 Hiroyuki Ono 細胞障害タンパク質ｍ毒素の発現方法
WO2006102652A2 (en) * 2005-03-24 2006-09-28 Neose Technologies, Inc. Expression of soluble, active eukaryotic glycosyltransferases in prokaryotic organisms
US20150353940A1 (en) 2013-08-05 2015-12-10 Absci, Llc Vectors for use in an inducible coexpression system
EP3015550A1 (de) * 2014-10-30 2016-05-04 Sanofi 21-Hydroxylierung von Steroiden
EP3683308A1 (de) 2015-06-10 2020-07-22 Toyama Prefectural University Herstellungsverfahren für mutiertes enzym in aktiver form, neues mutiertes enzym in aktiver form und herstellungsverfahren für gelöstes mutantes protein
CZ308223B6 (cs) * 2016-01-28 2020-03-11 Mikrobiologický Ústav Av Čr V.V.I. Způsob přípravy rekombinantní tyrosinasy
CN108456688A (zh) * 2017-02-21 2018-08-28 上海凯赛生物技术研发中心有限公司 一种基于t7启动子的重组表达质粒、转化子及其应用
CN120330119B (zh) * 2025-06-16 2025-12-05 齐鲁工业大学(山东省科学院) 一株高产谷氨酰胺转氨酶的工程菌及其构建方法与应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4758512A (en) * 1984-03-06 1988-07-19 President And Fellows Of Harvard College Hosts and methods for producing recombinant products in high yields
JPH08140671A (ja) * 1994-11-25 1996-06-04 H S P Kenkyusho:Kk 大腸菌変異株
JP3656277B2 (ja) * 1995-05-17 2005-06-08 味の素株式会社 組換えｄｎａ法によるトランスグルタミナーゼの効率的製造法

Also Published As

Publication number Publication date
DE69824487T2 (de) 2005-06-30
EP0885967A2 (de) 1998-12-23
CA2235468A1 (en) 1998-12-20
EP0885967A3 (de) 2000-06-21
DE69824487D1 (de) 2004-07-22
JPH119274A (ja) 1999-01-19
CA2235468C (en) 2008-06-17
US6159708A (en) 2000-12-12
JP3344618B2 (ja) 2002-11-11
EP0885967B1 (de) 2004-06-16

Similar Documents

Publication Publication Date Title
DE69824487D1 (de) Expressionsplasmide für Chaperone
NO972185L (no) Selektiv acylering av <epsilon>-aminogrupper
DE69913285D1 (de) DsbA/DsbB/DsbC/DsbD Expressionsplasmid
ATE44768T1 (de) Verfahren zur mikrobiologischen herstellung von menschlichem serum-albumin.
ATE279912T1 (de) Verfahren zur zelltransfektion mit liposomal- verkapselten nukleinsäuren
NO883592D0 (no) Enzym.
NO960839L (no) Bakterieeksporterte proteiner og acellulære vaksiner som er basert på disse
ATE334146T1 (de) Verfahren zur herstellung von erythropoietin frei von tierischen proteinen
ATE338114T1 (de) Multi-tumor abweichende wachstumsgene
IL139974A0 (en) Culture medium for culture of animal cell and method for producing protein using same
NO910982D0 (no) Uratoksydase-aktivt protein, rekombinant gen som koder for det, ekspresjonsvektor, mikroorganismer og transformerteceller.
DK619086A (da) Gm-csf-protein, derivater deraf, samt fremstilling og anvendelse af saadanne proteiner
FI852956A0 (fi) Menetelmä valmistaa uutta ihmisen tyypin I interferoniproteiinia
AU2003293664A1 (en) Resistance heating
DE69431922D1 (de) Glycosilierte und nichtglycolisierte bakterizide/die permeabilität erhoehende proteine und methoden zu ihrer herstellung
KR910012245A (ko) 신규한 폴리펩티드와 이들을 코드하는 발현가능한 dna시퀀스 및 그의 제조방법
DE69932697D1 (de) Plasmide welche die Trigger Faktoren Gene GroEL oder GroES expremieren
DE69838681D1 (de) Escherichia coli hochexpressionsvektor
IT1208514B (it) Vettori plasmidici ad espressione in escherichia coli e/o bacillussubtilis.
DK0781341T3 (da) Fremgangsmåde til fremstilling af rekombinante proteiner, plasmider og modificerede celler
IL113932A0 (en) A lactose repressor protein a gene coding therefor and a method for expressing and controlling the expression of said gene
ATE439430T1 (de) Mutanten für die herstellung von d-aminosäuren
DK38889D0 (da) Onkogen-indkodet polypeptid med vaekstfaktoraktivitet
IT8119759A0 (it) Umano, dna e plasmidi che polipeptide prodotto codificano per questa sequenza, microbiologicamente con la sequenza microorganismi che contengono di aminoacidi dell'interferone queste informazioni genetiche e processo per la loro preparazione.
MY104233A (en) Production of human prourokinase.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties